Canon Medical’s AI-Powered, Premium Large Bore CT Receives FDA Clearance

Canon Medical Systems USA, Inc. has received FDA clearance for the Aquilion Exceed LB CT system, giving clinicians the opportunity to see more during radiation therapy planning for accuracy, precision and speed.

FDA Clears MULTIX Impact C Ceiling-Mounted DR System

Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the MULTIX Impact C ceiling-mounted digital radiography (DR) system as well as the MULTIX Impact VA20, a new version of the established floor-mounted parent DR system.

FDA Approves Seno Medical’s Breast Cancer Diagnostic Technology

The Center for Devices and Radiological Health (CDRH) of the U.S. Food & Drug Administration (FDA) has granted Texas-based Seno Medical Instruments Inc.

Philips to Acquire Capsule Technologies Inc.

Royal Philips has signed an agreement to acquire Capsule Technologies Inc., a provider of medical device integration and data technologies for hospitals and healthcare organizations.

MITA Praises Bipartisan Group of Freshman Lawmakers for Supporting Device Tax Repeal

In a letter to Speaker Nancy Pelosi signed by 36 lawmakers, a bipartisan group of freshmen representatives led by Congressmen Ben McAdams and Ben Cline urged the House to permanently repeal the 2.3 percent medical device tax, the Medical Imaging & Technology Alliance (MITA) said today.

“Since the inception of the medical device tax, there has been growing bipartisan support to end this tax on innovation, and it has been suspended multiple times by Congress,” the lawmakers wrote. “However, absent Congressional action, the tax will be reinstated on January 1, 2020, and will jeopardize medical technology research, job creation, and our constituents’ access to care. Ensuring access to medical innovation will improve patient health and benefit our economy by enhancing treatments for chronic conditions and increasing labor force participation and productivity. Bipartisan majorities have suspended the tax in previous Congresses, and a permanent repeal would encourage innovative medical research. As cosponsors of the Protect Medical Innovation Act, we believe this Congress must take decisive action to fully repeal the medical device tax this year.”

The medical device tax is a 2.3 percent excise tax to the sale of nearly any medical devices sold in the country—from sterile surgical gloves to MRI machines and CT scanners. Between 2013 and 2015 when the medical device was collected, medical device sales declined by $188 million, the industry reportedly lost more than 30,000 jobs and the tax reduced industry research and development spending by $34 million.

“We appreciate the leadership of Congressmen McAdams and Cline and the bipartisan support of the freshman class for demonstrating to leadership and their colleagues the importance of acting now to mitigate the negative effects of reinstating the medical device tax,” said Dennis Durmis, Chair of MITA Board of Directors. “The establishment of the device tax has had a significant negative impact to both patients and the economy while in effect and must be fully – and finally – repealed this year.”

The full text of the letter is available here.



Submit a Comment

Your email address will not be published. Required fields are marked *